Doxl2 inhibitors are a class of chemical compounds that specifically target and inhibit the function of Doxl2, a protein that is believed to play a role in transcriptional regulation and gene expression. Doxl2 is likely involved in controlling the activity of specific genes, possibly through its interaction with DNA or chromatin, influencing key developmental or cellular processes. Proteins like Doxl2 may serve as transcription factors or co-regulators that help modulate the expression of genes linked to differentiation, growth, or cellular responses to external signals. By inhibiting Doxl2, researchers can study its role in these gene regulatory pathways and determine how its activity impacts transcriptional networks and cellular behavior.
The mechanism of Doxl2 inhibitors typically involves binding to critical domains of the Doxl2 protein, such as DNA-binding motifs or regions responsible for interacting with other transcriptional machinery. These inhibitors may prevent Doxl2 from binding to gene promoter regions or disrupt its ability to recruit co-regulators that are essential for transcriptional activation or repression. Structurally, Doxl2 inhibitors are designed to either mimic natural ligands or interact with specific binding pockets or residues required for its regulatory activity. By blocking Doxl2's function, researchers can explore how transcription factors like Doxl2 govern gene expression patterns and the broader implications of its role in cellular differentiation and development. The use of Doxl2 inhibitors provides valuable insights into the molecular pathways that control gene expression, helping to unravel the complex networks that regulate cell function and identity at the transcriptional level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aminoguanidine hydrochloride | 1937-19-5 | sc-202931 sc-202931A sc-202931B | 10 g 25 g 50 g | $32.00 $43.00 $94.00 | 2 | |
Aminoguanidine, a diamine oxidase inhibitor, directly targets the enzyme's active site, impeding its diamine oxidase activity and reducing the conversion of primary amines, influencing the amine metabolic process. | ||||||
Pargyline hydrochloride | 306-07-0 | sc-215676 sc-215676A | 500 mg 1 g | $39.00 $82.00 | 2 | |
Pargyline, a monoamine oxidase inhibitor, indirectly influences Doxl2 by modulating monoamine oxidase activity, potentially impacting the degradation of amines and their metabolic processes. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride, an inhibitor of copper ion transport, indirectly influences Doxl2 by modulating copper ion availability, potentially affecting its copper ion binding activity and amine metabolic processes. | ||||||
Penicillamine | 52-67-5 | sc-205795 sc-205795A | 1 g 5 g | $46.00 $96.00 | ||
Penicillamine, a copper chelator, indirectly influences Doxl2 by chelating copper ions, potentially impacting its copper ion binding activity and amine metabolic processes. | ||||||
Diphenhydramine hydrochloride | 147-24-0 | sc-204729 sc-204729A sc-204729B | 10 g 25 g 100 g | $52.00 $84.00 $124.00 | 4 | |
Diphenhydramine, an H1 receptor antagonist, indirectly influences Doxl2 by modulating histamine metabolism, potentially impacting the amine metabolic process and response to antibiotics. | ||||||
Captopril | 62571-86-2 | sc-200566 sc-200566A | 1 g 5 g | $49.00 $91.00 | 21 | |
Captopril, an angiotensin-converting enzyme inhibitor, indirectly influences Doxl2 by modulating vasodilation, potentially impacting the response to antibiotics and amine metabolic processes. | ||||||
Propargylamine | 2450-71-7 | sc-253321 sc-253321A sc-253321B sc-253321C | 1 g 5 g 100 g 500 g | $33.00 $77.00 $260.00 $901.00 | 1 | |
Propargylamine, an irreversible monoamine oxidase inhibitor, directly inhibits the enzyme, reducing monoamine oxidase activity and influencing the degradation of amines, potentially impacting amine metabolic processes. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram, an aldehyde dehydrogenase inhibitor, indirectly influences Doxl2 by modulating acetaldehyde metabolism, potentially impacting the response to antibiotics and amine metabolic processes. | ||||||